As a leading aqua health company, Elanco Aqua has a broad portfolio of products on the market including vaccines and treatments to combat the most damaging diseases and parasites in fish.

Aquaculture is a priority at Elanco Aqua and we are committed to enabling fish farmers meet the need for productivity through healthier fish now and in the future. Our focus on innovation combined with state-of-the-art research facilities means that we are often first to license new products and technologies such as the first Nucleic Acid Vaccine.

With our ongoing dedication to Aquaculture and a healthy pipeline of new products in development, we are uniquely qualified to support sustainable fish production while helping to conserve many endangered fisheries and fish stocks.